154 related articles for article (PubMed ID: 17585753)
1. Acridone-based inhibitors of inosine 5'-monophosphate dehydrogenase: discovery and SAR leading to the identification of N-(2-(6-(4-ethylpiperazin-1-yl)pyridin-3-yl)propan-2-yl)-2- fluoro-9-oxo-9,10-dihydroacridine-3-carboxamide (BMS-566419).
Watterson SH; Chen P; Zhao Y; Gu HH; Dhar TG; Xiao Z; Ballentine SK; Shen Z; Fleener CA; Rouleau KA; Obermeier M; Yang Z; McIntyre KW; Shuster DJ; Witmer M; Dambach D; Chao S; Mathur A; Chen BC; Barrish JC; Robl JA; Townsend R; Iwanowicz EJ
J Med Chem; 2007 Jul; 50(15):3730-42. PubMed ID: 17585753
[TBL] [Abstract][Full Text] [Related]
2. Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.
Nakanishi T; Morokata T; Kubo K; Umeno H; Eikyu Y; Kozuki Y; Seki N
Int Immunopharmacol; 2010 Jan; 10(1):91-7. PubMed ID: 19840872
[TBL] [Abstract][Full Text] [Related]
3. Inosine 5'-monophosphate dehydrogenase inhibitors for the treatment of autoimmune diseases.
Ratcliffe AJ
Curr Opin Drug Discov Devel; 2006 Sep; 9(5):595-605. PubMed ID: 17002220
[TBL] [Abstract][Full Text] [Related]
4. Characterization of pharmacological efficacy of VX-148, a new, potent immunosuppressive inosine 5'-monophosphate dehydrogenase inhibitor.
Jain J; Almquist SJ; Heiser AD; Shlyakhter D; Leon E; Memmott C; Moody CS; Nimmesgern E; Decker C
J Pharmacol Exp Ther; 2002 Sep; 302(3):1272-7. PubMed ID: 12183689
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo characterization of AS2643361, a novel and highly potent inosine 5'-monophosphate dehydrogenase inhibitor.
Nakanishi T; Kozuki Y; Eikyu Y; Kubo K; Kawato Y; Marui T; Seki N; Masunaga T; Tamura K; Morokata T
Eur J Pharmacol; 2012 Jan; 674(1):58-63. PubMed ID: 22075081
[TBL] [Abstract][Full Text] [Related]
6. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
Vethe NT; Bergan S
Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
[TBL] [Abstract][Full Text] [Related]
7. Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on renal fibrosis in unilateral ureteral obstruction in rats.
Nakanishi T; Morokata T; Noto T; Kubo K; Umeno H; Kinugasa F; Eikyu Y; Kozuki Y; Seki N
Int Immunopharmacol; 2010 Nov; 10(11):1434-9. PubMed ID: 20832515
[TBL] [Abstract][Full Text] [Related]
8. Novel indole inhibitors of IMPDH from fragments: synthesis and initial structure-activity relationships.
Beevers RE; Buckley GM; Davies N; Fraser JL; Galvin FC; Hannah DR; Haughan AF; Jenkins K; Mack SR; Pitt WR; Ratcliffe AJ; Richard MD; Sabin V; Sharpe A; Williams SC
Bioorg Med Chem Lett; 2006 May; 16(9):2539-42. PubMed ID: 16483773
[TBL] [Abstract][Full Text] [Related]
9. Discovery of N-[2-[2-[[3-methoxy-4-(5-oxazolyl)phenyl]amino]-5-oxazolyl]phenyl]-N-methyl-4- morpholineacetamide as a novel and potent inhibitor of inosine monophosphate dehydrogenase with excellent in vivo activity.
Dhar TG; Shen Z; Guo J; Liu C; Watterson SH; Gu HH; Pitts WJ; Fleener CA; Rouleau KA; Sherbina NZ; McIntyre KW; Shuster DJ; Witmer MR; Tredup JA; Chen BC; Zhao R; Bednarz MS; Cheney DL; MacMaster JF; Miller LM; Berry KK; Harper TW; Barrish JC; Hollenbaugh DL; Iwanowicz EJ
J Med Chem; 2002 May; 45(11):2127-30. PubMed ID: 12014950
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological evaluation of novel inosine 5'-monophosphate dehydrogenase (IMPDH) inhibitors.
Dunkern T; Chavan S; Bankar D; Patil A; Kulkarni P; Kharkar PS; Prabhu A; Goebel H; Rolser E; Burckhard-Boer W; Arumugam P; Makhija MT
J Enzyme Inhib Med Chem; 2014 Jun; 29(3):408-19. PubMed ID: 23663081
[TBL] [Abstract][Full Text] [Related]
11. Antifibrotic actions of mycophenolic acid.
Morath C; Schwenger V; Beimler J; Mehrabi A; Schmidt J; Zeier M; Muranyi W
Clin Transplant; 2006; 20 Suppl 17():25-9. PubMed ID: 17100698
[TBL] [Abstract][Full Text] [Related]
12. Novel 7-methoxy-6-oxazol-5-yl-2,3-dihydro-1H-quinazolin-4-ones as IMPDH inhibitors.
Birch HL; Buckley GM; Davies N; Dyke HJ; Frost EJ; Gilbert PJ; Hannah DR; Haughan AF; Madigan MJ; Morgan T; Pitt WR; Ratcliffe AJ; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
Bioorg Med Chem Lett; 2005 Dec; 15(23):5335-9. PubMed ID: 16202581
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and optimization of arylsulfonylpiperazines as a novel class of inhibitors of 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1).
Sun D; Wang Z; Cardozo M; Choi R; Degraffenreid M; Di Y; He X; Jaen JC; Labelle M; Liu J; Ma J; Miao S; Sudom A; Tang L; Tu H; Ursu S; Walker N; Yan X; Ye Q; Powers JP
Bioorg Med Chem Lett; 2009 Mar; 19(5):1522-7. PubMed ID: 19181519
[TBL] [Abstract][Full Text] [Related]
14. Periodic, partial inhibition of IkappaB Kinase beta-mediated signaling yields therapeutic benefit in preclinical models of rheumatoid arthritis.
Gillooly KM; Pattoli MA; Taylor TL; Chen L; Cheng L; Gregor KR; Whitney GS; Susulic V; Watterson SH; Kempson J; Pitts WJ; Booth-Lute H; Yang G; Davies P; Kukral DW; Strnad J; McIntyre KW; Darienzo CJ; Salter-Cid L; Yang Z; Wang-Iverson DB; Burke JR
J Pharmacol Exp Ther; 2009 Nov; 331(2):349-60. PubMed ID: 19652024
[TBL] [Abstract][Full Text] [Related]
15. Development and application of a high-performance liquid chromatography-based assay for determination of the activity of inosine 5'-monophosphate dehydrogenase in whole blood and isolated mononuclear cells.
Albrecht W; Storck M; Pfetsch E; Martin W; Abendroth D
Ther Drug Monit; 2000 Jun; 22(3):283-94. PubMed ID: 10850395
[TBL] [Abstract][Full Text] [Related]
16. Quinazolinethiones and quinazolinediones, novel inhibitors of inosine monophosphate dehydrogenase: synthesis and initial structure-activity relationships.
Buckley GM; Davies N; Dyke HJ; Gilbert PJ; Hannah DR; Haughan AF; Hunt CA; Pitt WR; Profit RH; Ray NC; Richard MD; Sharpe A; Taylor AJ; Whitworth JM; Williams SC
Bioorg Med Chem Lett; 2005 Feb; 15(3):751-4. PubMed ID: 15664851
[TBL] [Abstract][Full Text] [Related]
17. The conformation of NADH bound to inosine 5'-monophosphate dehydrogenase determined by transferred nuclear Overhauser effect spectroscopy.
Schalk-Hihi C; Zhang YZ; Markham GD
Biochemistry; 1998 May; 37(20):7608-16. PubMed ID: 9585576
[TBL] [Abstract][Full Text] [Related]
18. Novel methylenephosphophosphonate analogues of mycophenolic adenine dinucleotide. Inhibition of inosine monophosphate dehydrogenase.
Rejman D; Olesiak M; Chen L; Patterson SE; Wilson D; Jayaram HN; Hedstrom L; Pankiewicz KW
J Med Chem; 2006 Aug; 49(16):5018-22. PubMed ID: 16884314
[TBL] [Abstract][Full Text] [Related]
19. 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction.
Kolasa T; Matulenko MA; Hakeem AA; Patel MV; Mortell K; Bhatia P; Henry R; Nakane M; Hsieh GC; Terranova MA; Uchic ME; Miller LN; Chang R; Donnelly-Roberts DL; Namovic MT; Hollingsworth PR; Martino B; El Kouhen O; Marsh KC; Wetter JM; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2006 Aug; 49(17):5093-109. PubMed ID: 16913699
[TBL] [Abstract][Full Text] [Related]
20. Liquid chromatography-coupled tandem mass spectrometry based assay to evaluate inosine-5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells from stem cell transplant recipients.
Laverdière I; Caron P; Couture F; Guillemette C; Lévesque E
Anal Chem; 2012 Jan; 84(1):216-23. PubMed ID: 22092180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
